DMPA-SC stock: Cross-site trends by facility type [PDF]
Contraception: X, 2022 Objectives: To measure trends in the supply of DMPA-SC in public and private health facilities and compare with other prominent modern methods. Study design: We used repeated cross-sectional data from service-delivery-point surveys in six settings ...
Sophia Magalona +8 more
doaj +4 more sources
Scale-up of the DMPA-SC in Nigeria: Why policy matters [PDF]
BMC Women's Health, 2022 Background Injectable contraceptives have contributed substantially to Nigeria's rise in modern family planning methods usage. They are one of the most commonly used and preferred means of contraception among women in the country.
Oluwaseun Akinyemi +5 more
doaj +4 more sources
Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda [PDF]
Contraception: X, 2021 Objectives: To what extent is DMPA-SC reaching new users versus encouraging method switching among existing users? Though increasingly-popular, little is known about characteristics of women using DMPA-SC in SSA.
Philip Anglewicz +7 more
doaj +4 more sources
Perspectives on DMPA-SC for self-injection among adolescents with unmet need for contraception in Malawi [PDF]
Frontiers in Global Women's Health, 2023 IntroductionMalawi has made progress in expanding access to modern contraceptive methods over the last decade, including the introduction of depot-medroxyprogesterone acetate subcutaneous (DMPA-SC) in 2018.
Gracious Ali +6 more
doaj +4 more sources
Cost-effectiveness of self-injected DMPA-SC compared with health-worker-injected DMPA-IM in Senegal [PDF]
Contraception: X, 2019 Objectives: To evaluate the cost-effectiveness of self-injected subcutaneous depot medroxyprogesterone acetate (DMPA-SC) compared to health-worker-administered intramuscular DMPA (DMPA-IM) in Senegal and to assess how including practice or demonstration ...
Mercy Mvundura +5 more
doaj +4 more sources
Trends in subcutaneous depot medroxyprogesterone acetate (DMPA-SC) use in Burkina Faso, the Democratic Republic of Congo and Uganda [PDF]
Contraception: X, 2019 Objectives: Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is seen as a valuable innovation in family planning, but little is known about trends in DMPA-SC use or characteristics of users.
Philip Anglewicz +7 more
doaj +4 more sources
Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi. [PDF]
PLOS Global Public Health, 2023 Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018, Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC.
Chelsey Porter Erlank +6 more
doaj +4 more sources
Feasibility and acceptability of DMPA-SC self-injection in Addis Ababa, Ethiopia: a mixed-methods study [PDF]
Reproductive HealthBackground Depot Medroxyprogesterone Acetate (DMPA) in a prefilled auto-disabled subcutaneous injectable contraceptive (Uniject™) can be administered by community health workers and clients.
Aderaw Anteneh +8 more
doaj +3 more sources
Lessons from the scale-up of provider-administered and self-injection of DMPA-SC in Nigeria: a landscape assessment [PDF]
BMC Women's HealthBackground Nigeria is the seventh-most populous country in the world. Its high fertility rate and unmet need for family planning contribute to the increasing population size.
Adewole A. Adefalu +9 more
doaj +4 more sources
Influence of Movement Restriction During the COVID-19 Pandemic on Uptake of DMPA-SC and Other Injectable Contraceptive Methods in Nigeria [PDF]
Open Access Journal of ContraceptionAdewole Adebola Adefalu,1 Olufunke Abimbola Bankole,2 Funmilayo Olabode,2 Mojuba Bimbo Afolabi,2 Miranda Atare Buba,2 Victor Dafe,2 Mishael Nnanna Kalu,2 Emily Watkins3 1JSI Research & Training Institute, Inc., Atlanta, GA, USA; 2JSI Research & ...
Adefalu AA +7 more
doaj +3 more sources